SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-002133
Filing Date
2023-03-06
Accepted
2023-03-06 16:40:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 FULCRUM THERAPEUTICS, INC. p23-1069sc13g.htm SC 13G 107602
  Complete submission text file 0000902664-23-002133.txt   109181
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Subject) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91080 | Film No.: 23709455
SIC: 2834 Pharmaceutical Preparations